Genomic Services Market: Industry Growth and Forecast 2024-2032
The Genomic Services Market was valued at USD 25.56 billion in 2023 and is projected to reach USD 80.91 billion by 2031, growing at a compound annual growth rate (CAGR) of 15.5% from 2024 to 2031. The increasing integration of genomic technologies in drug discovery, diagnostics, and clinical research is a major driving force behind the expanding genomic services market size.
As precision medicine and genetic research continue to evolve, the demand for advanced genomic services has surged significantly. From sequencing and bioinformatics to gene expression and mutation analysis, service providers are playing a crucial role in advancing healthcare outcomes. Technological innovations such as next-generation sequencing (NGS), AI-driven genomic data interpretation, and decreasing sequencing costs have made these services more accessible and affordable. This trend is fueling widespread adoption across research institutions, pharmaceutical companies, and clinical laboratories.
Get Free Sample Report @ https://www.snsinsider.com/sample-request/2873
Key Genomics Services Companies
- Thermo Fisher Scientific, Inc.
- 23andMe, Inc.
- Agilent Technologies
- Bio-Rad Laboratories, Inc.
- BGI Genomics
- Color Genomics, Inc.
- Danaher Corporation
- GE Healthcare
- Illumina, Inc.
- Myriad Genetics, Inc.
- Eppendorf AG
- Eurofins Scientific
- F. Hoffmann-La Roche Ltd.
- Oxford Nanopore Technologies
- Pacific Biosciences of California, Inc.
- QIAGEN N.V.
- Quest Diagnostics Incorporated, and others.
Key Highlights:
- Market size expected to reach USD 80.91 billion by 2031 at a CAGR of 15.5%
- Growth driven by the rising demand for personalized medicine and genetic testing
- Rapid adoption of NGS and bioinformatics platforms
- Increasing funding for genomic research from government and private sectors
- Expanding use of genomics in oncology, rare diseases, and pharmacogenomics
- North America holds the largest market share, with Asia-Pacific showing fastest growth
Future Scope:
The future of the genomic services market is poised for remarkable transformation as personalized healthcare becomes mainstream. Advancements in AI, machine learning, and cloud computing are enabling more sophisticated analysis of genomic data, leading to faster diagnoses and tailored treatments. Additionally, global collaborations in genomic research and growing awareness among consumers about genetic health are expected to further propel market growth.
Conclusion:
The genomic services market is undergoing rapid expansion, driven by technological innovations, rising healthcare demand, and a shift toward personalized treatment solutions. With strong market dynamics and evolving research landscapes, stakeholders in this field are well-positioned to capitalize on emerging opportunities and shape the future of precision medicine.
Contact Us:
Jagney Dave - Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Other Related Reports:
Comments
0 comment